The research investigates the importance of defining legal accountability for pharmaceutical products promoted via online platforms. As the internet increasingly becomes a marketplace for medications, the protection of consumers and the safety of products emerge as paramount issues. This study aids in improving the safety and quality benchmarks for pharmaceutical products available online, thereby reducing potential harm and side effects for consumers. It analyzes both contractual and non-contractual liabilities of sellers in the online pharmaceutical sector, along with the degree of responsibility that pharmaceutical companies hold when consumers experience harm from products acquired through online means. Furthermore, the research outlines the legal options accessible to consumers who incur damages from pharmaceutical products purchased online, including avenues for seeking compensation. Employing a descriptive, analytical, and comparative methodological approach, the study concludes that existing legal frameworks frequently do not adequately address the intricacies associated with online pharmaceutical sales and marketing. It emphasizes that, in contrast to conventional regulations, online sellers may escape accountability due to jurisdictional challenges, and numerous legal systems lack specific provisions governing online pharmaceutical marketing. Consequently, there is a need to depend on broader consumer protection and civil law to uphold consumer rights. The research suggests the establishment of particular legal measures to govern the online marketing and sale of pharmaceuticals, thereby ensuring that both manufacturers and online retailers are held responsible for any damages resulting from their products. Additionally, it calls for severe penalties for those who fail to adhere to safety regulations and for manufacturers engaged in deceptive practices concerning online pharmaceutical sales.